Post Trial Access

for Pharmaceutical Companies

Post-trial access  may be managed via open-label roll-over study design, but there may be other alternatives that are appropriate for your development compound.  


Our expertise is to develop and manage Post-Trial Access programs.  Let us find the solution that offers you optimal flexibility, efficiency and value.